Physician profile
Dmitriy Nikolavsky
NPI 1144435041
$7,128.96
in general payments reported to CMS, 2019-2025
7 companies · $6,238 in 2025
The $6,238 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $163 · 2023: $218 · 2024: $510 · 2025: $6,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,577 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,576.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $889.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uromedica, Incorporated | $6,076.98 | 2025 | Proact |
| Lsi Solutions INC | $485.98 | 2024-2025 | Running Device, Jnw Urtrac, Ti-Knot |
| Boston Scientific Corporation | $217.99 | 2022-2023 | Ams 700 |
| Coloplast Corp | $163.08 | 2023 | Titan |
| Innovation Technologies INC | $123.38 | 2024 | Irrisept |
| Urogen Pharma, INC. | $38.72 | 2024 | |
| Astellas Pharma Global Development | $22.83 | 2025 | Xtandi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitriy Nikolavsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.